Artificial neural network identified a 20-gene panel in predicting immunotherapy response and survival benefits after anti-PD1/PD-L1 treatment in glioblastoma patients.

Yaning WangZihao WangXiaopeng GuoYaning CaoHao XingYuekun WangBing XingYu WangYong YaoWenbin Ma

Published in: Cancer medicine (2024)

The 20-gene panel developed by the ANN could be a promising biomarker for predicting immunotherapy response and prognostic benefits in ICI-treated GBM patients and may guide oncologists to accurately select potential responders for the preferential use of ICIs.

Keyphrases

end stage renal disease
newly diagnosed
neural network
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
genome wide
risk assessment
climate change